HealthEquity Total Assets 2014-2024 | HQY
HealthEquity total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- HealthEquity total assets for the quarter ending January 31, 2024 were $3.164B, a 2.42% increase year-over-year.
- HealthEquity total assets for 2024 were $3.164B, a 2.42% increase from 2023.
- HealthEquity total assets for 2023 were $3.089B, a 0.59% decline from 2022.
- HealthEquity total assets for 2022 were $3.107B, a 14.64% increase from 2021.
| HealthEquity Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $3,164 |
| 2023 | $3,089 |
| 2022 | $3,107 |
| 2021 | $2,710 |
| 2020 | $2,565 |
| 2019 | $510 |
| 2018 | $369 |
| 2017 | $279 |
| 2016 | $220 |
| 2015 | $159 |
| 2014 | $55 |
| 2013 | $46 |
| HealthEquity Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-01-31 | $3,164 |
| 2023-10-31 | $3,094 |
| 2023-07-31 | $3,066 |
| 2023-04-30 | $3,035 |
| 2023-01-31 | $3,089 |
| 2022-10-31 | $3,065 |
| 2022-07-31 | $3,074 |
| 2022-04-30 | $3,065 |
| 2022-01-31 | $3,107 |
| 2021-10-31 | $3,100 |
| 2021-07-31 | $3,149 |
| 2021-04-30 | $3,162 |
| 2021-01-31 | $2,710 |
| 2020-10-31 | $2,657 |
| 2020-07-31 | $2,664 |
| 2020-04-30 | $2,562 |
| 2020-01-31 | $2,565 |
| 2019-10-31 | $2,560 |
| 2019-07-31 | $1,098 |
| 2019-04-30 | $597 |
| 2019-01-31 | $510 |
| 2018-10-31 | $478 |
| 2018-07-31 | $455 |
| 2018-04-30 | $418 |
| 2018-01-31 | $369 |
| 2017-10-31 | $356 |
| 2017-07-31 | $331 |
| 2017-04-30 | $303 |
| 2017-01-31 | $279 |
| 2016-10-31 | $264 |
| 2016-07-31 | $251 |
| 2016-04-30 | $232 |
| 2016-01-31 | $220 |
| 2015-10-31 | $212 |
| 2015-07-31 | $203 |
| 2015-04-30 | $165 |
| 2015-01-31 | $159 |
| 2014-10-31 | $153 |
| 2014-07-31 | $66 |
| 2014-04-30 | $0 |
| 2014-01-31 | $0 |
| 2013-10-31 | $0 |
| 2013-07-31 | $0 |
| 2013-01-31 | $46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $6.851B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.212B | 15.32 |
| Cencora (COR) | United States | $47.337B | 18.89 |
| ICON (ICLR) | Ireland | $24.074B | 23.75 |
| DiDi Global (DIDIY) | China | $22.638B | 0.00 |
| Avantor (AVTR) | United States | $16.482B | 22.71 |
| CochLear (CHEOY) | $13.356B | 0.00 | |
| Viatris (VTRS) | United States | $13.340B | 3.81 |
| Revvity (RVTY) | United States | $12.276B | 21.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.721B | 21.37 |
| Medpace Holdings (MEDP) | United States | $11.598B | 42.15 |
| Solventum (SOLV) | United States | $11.046B | 0.00 |
| Natera (NTRA) | United States | $10.540B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| Bausch + Lomb (BLCO) | Canada | $5.032B | 19.35 |
| Doximity (DOCS) | United States | $4.630B | 34.47 |
| Organon (OGN) | United States | $4.566B | 4.42 |
| Sotera Health (SHC) | United States | $3.085B | 15.14 |
| Progyny (PGNY) | United States | $3.064B | 51.42 |
| Surgery Partners (SGRY) | United States | $2.965B | 27.55 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.658B | 134.60 |
| Premier (PINC) | United States | $2.491B | 9.12 |
| Teladoc Health (TDOC) | United States | $2.232B | 0.00 |
| Agilon Health (AGL) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.133B | 6.90 |
| BrightSpring Health Services (BTSG) | United States | $1.762B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.444B | 0.00 | |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.964B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.596B | 3.94 |
| Auna S.A (AUNA) | Luxembourg | $0.549B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.507B | 45.96 |
| MultiPlan (MPLN) | United States | $0.475B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| CareDx (CDNA) | United States | $0.418B | 0.00 |
| LifeMD (LFMD) | United States | $0.412B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.356B | 57.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.286B | 3.79 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.249B | 0.00 |
| Sharecare (SHCR) | United States | $0.227B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.119B | 40.00 |
| Oncology Institute (TOI) | United States | $0.091B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.015B | 0.00 | |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |